.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Mallinckrodt
Fish and Richardson
Medtronic
Farmers Insurance
Citi
Cerilliant
McKesson
Julphar

Generated: November 22, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: samarium sm-153 lexidronam pentasodium

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lantheus Medical
QUADRAMET
samarium sm-153 lexidronam pentasodium
INJECTABLE;INJECTION020570NDALantheus Medical Imaging, Inc.11994-016-013 mL in 1 VIAL, SINGLE-DOSE (11994-016-01)
Lantheus Medical
QUADRAMET
samarium sm-153 lexidronam pentasodium
INJECTABLE;INJECTION020570NDAJazz Pharmaceuticals, Inc.57902-860-033 mL in 1 VIAL, SINGLE-DOSE (57902-860-03)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Deloitte
QuintilesIMS
Cantor Fitzgerald
Federal Trade Commission
McKesson
Healthtrust
Chinese Patent Office
Fuji

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot